Dyne Therapeutics Inc (DYN)’s latest performance is not what we had anticipated

On Tuesday, Dyne Therapeutics Inc (NASDAQ: DYN) was 10.71% up from the session before settling in for the closing price of $33.61. A 52-week range for DYN has been $6.40 – $36.60.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


When this article was written, the company’s average yearly earnings per share was at 23.78%. With a float of $68.32 million, this company’s outstanding shares have now reached $97.88 million.

In an organization with 141 employees, it is important to assess its efficiency.

Dyne Therapeutics Inc (DYN) Insider Updates

Also, it is sometimes useful to examine the sentiment of large-scale investors toward Dyne Therapeutics Inc stocks. The insider ownership of Dyne Therapeutics Inc is 30.20%, while institutional ownership is 68.21%. The most recent insider transaction that took place on Jun 24 ’24, was worth 359,059. In this transaction Chief Operating Officer of this company sold 10,163 shares at a rate of $35.33, taking the stock ownership to the 148,792 shares. Before that another transaction happened on Jun 21 ’24, when Company’s Chief Operating Officer sold 29,787 for $35.01, making the entire transaction worth $1,042,843. This insider now owns 148,792 shares in total.

Dyne Therapeutics Inc (DYN) Performance Highlights and Predictions

According to the Wall Street analysts, stocks earnings will be around 23.78% per share during the next fiscal year.

Dyne Therapeutics Inc (NASDAQ: DYN) Trading Performance Indicators

You can see what Dyne Therapeutics Inc (DYN) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 21.83.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.97, a number that is poised to hit -0.72 in the next quarter and is forecasted to reach -3.07 in one year’s time.

Technical Analysis of Dyne Therapeutics Inc (DYN)

Let’s dig in a bit further. During the last 5-days, its volume was 0.72 million. That was inferior than the volume of 1.71 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 55.53%. Additionally, its Average True Range was 1.86.

During the past 100 days, Dyne Therapeutics Inc’s (DYN) raw stochastic average was set at 99.94%, which indicates a significant increase from 99.82% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 64.08% in the past 14 days, which was lower than the 70.65% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $30.94, while its 200-day Moving Average is $20.49. However, in the short run, Dyne Therapeutics Inc’s stock first resistance to watch stands at $38.55. Second resistance stands at $39.89. The third major resistance level sits at $42.56. If the price goes on to break the first support level at $34.54, it is likely to go to the next support level at $31.87. Assuming the price breaks the second support level, the third support level stands at $30.53.

Dyne Therapeutics Inc (NASDAQ: DYN) Key Stats

There are 87,383K outstanding shares of the company, which has a market capitalization of 3.64 billion. As of now, sales total 0 K while income totals -235,940 K. Its latest quarter income was 0 K while its last quarter net income were -65,650 K.